News | Radiopharmaceuticals and Tracers | August 10, 2015

Illinois Health and Science Completes Acquisition of IBA Molecular North America

Transaction includes all of IBAM NA’s cyclotron sites and R&D facilities

IBA Molecular North America, IBAM NA, acquisition, Illinois Health and Science, IBA S.A.

August 10, 2015 — IBA (Ion Beam Applications S.A.) announced the completion of the divestiture of IBA Molecular North America Inc. (IBAM NA) to Illinois Health and Science (IHS), a non-profit healthcare system. 

IBAM NA is the U.S. subsidiary of IBA Molecular (IBAM), a joint-venture owned by IBA S.A. and SK Capital Partners. The acquisition includes all of IBAM NA’s cyclotron sites and research and development facilities.

The proceeds will be used to repay outstanding debt at IBAM and to make a distribution to IBAM’s shareholders (IBA S.A. owns 40 percent of IBAM). The transaction is not expected to have a significant impact on IBA’s 2015 profits and loss (P&L) but will generate cash proceeds of approximately EUR 10 million for IBA during the third quarter of 2015.

For more information: www.ibamolecular.com

Related Content

News | Business | September 19, 2017
September 19, 2017 — Invicro LLC, a provider of imaging services and software for research and drug development, anno
ScImage and Invia Partnership Announced
News | PACS | September 19, 2017
ScImage Inc. and Invia Imaging Solutions recently announced formation of a joint partnership at the American Society of...
Toshiba Highlights Latest CT Advancements at RSNA 2017
News | Computed Tomography (CT) | September 18, 2017
Toshiba Medical announced that it will display several new enhancements to its existing computed tomography (CT)...
Philips Launches CardioMD IV Cardiac SPECT Solution at ASNC 2017
Technology | SPECT Imaging | September 15, 2017
September 15, 2017 — Philips highlighted its newest solution for...
Double Targeting Ligands to Identify and Treat Prostate Cancer

The mice were imaged with small-animal PET/CT using 124I-RPS-027 (7.4 MBq [200 μCi]). Credit: JM Kelly et al., Department of Radiology, Weill Cornell Medicine, New York, NY

News | Prostate Cancer | September 14, 2017
Researchers have demonstrated a new, effective way to precisely identify and localize prostate cancer tumors while...
Blue Earth Diagnostics Announcing Results of FALCON PET/CT Trial at ASTRO 2017
News | PET-CT | September 13, 2017
September 13, 2017 — Blue Earth Diagnostics announced the upcoming oral presentation of initial results from the FALC
FDG-PET/CT Predicts Melanoma Patients' Response to Immune Checkpoint Inhibitor Therapy
News | PET-CT | September 07, 2017
September 7, 2017 — Advanced melanoma has a poor prognosis, but immune checkpoint inhibitor therapy can be effective
German Team Optimizing Therapy Planning for Cancers of the Liver
News | Interventional Radiology | August 29, 2017
Radioembolization is a therapy method used for liver tumors that are uncurable with surgery or chemotherapy. Thorough...
Sponsored Content | Videos | Nuclear Imaging | August 24, 2017
Prem Soman, M.D., director of nuclear cardiology at the Heart and Vascular Institute, University of Pittsburgh, and p
Overlay Init